Abstract
Women with primary dysmenorrhea have myometrial hyperactivity and reduced uterine blood flow during pain (1). We studied the possible involvement of vasopressin in the induction of these uterine changes. We also investigated the influence of an orally active vasopressin V1a antagonist, SR 49059, on vasopressin-induced smooth muscle activity of the non-pregnant uterus.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Åkerlund M, Anderson KE, Ingemarsson I 1976 Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhea. BrJ Obstet Gynaecol 83:673–678
Åkerlund M, Strömberg P, Forsling ML 1979 Primary dysmenorrhea and vasopressin. Br J Obstet Gynaecol 86:484–487
Strömberg P, Åkerlund M, Forsling ML, Granstrom E, Kindahl H 1984 Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet Gynecol Scand 63:533–538
Ekström P, Alm P, Åkerlund M 1991 Differences in vasomotor responses between main stem and smaller branches of the human uterine artery. Acta Obstet Gynecol Scand 70:429–433
Ekström P, Åkerlund M, Forsling M, Kindahl H, Laudanski T, Mrugacz G 1992 Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment - effects on uterine contractility. BrJ Obstet Gynaecol 99:680–684
Bossmar T, Forsling ML, Åkerlund M 1995 Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women. Acta Obstet Gynecol Scand 74:544–548
Bossmar T, Åkerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M 1995 Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. BrJ Obstet Gynaecol 102:907–912
Åkerlund M 1987 Can primary dysmenorrhea be alleviated by a vasopressin antagonist? Results of a pilot study. Acta Obstet Gynecol Scand 66:459–461
Åkerlund, M, Strömberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J, Melin P 1987 Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 94:1040–1044
Goodwin TM, Valenzuela GJ, Silver H, Creasy G 1996 Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 88:331–336
Goodwin TM, Valenzuela GJ, Silver H, Hayashi R, Creasy G, Lane R 1996 Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 13:143–146
Bossmar T, Rasmussen T, Åkerlund M 1996 Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium. Acta Obstet Gynecol Scand 75:516–519
Kostzrewska A, Laudanski T, Steinwall M, Bossmar T, Serradeil-le Gal C, Åkerlund M 1997 Acta Obstet Gynecol Scand 76:
Bossmar T, Brouard R, Döberl A, Åkerlund M 1997 Effects of SR 49059, an orally active V la vasopressin receptor antagonist, on vasopressin-induced uterine contractions. BrJ Obstet Gynaecol 104:471–477
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Åkerlund, M., Bossmar, T., Brouard, R., Steinwall, M. (1998). Evidence for an Involvement of Vasopressin in Mechanism of Primary Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor Antagonist, SR 49059, on the Uterus of Non-Pregnant Women. In: Zingg, H.H., Bourque, C.W., Bichet, D.G. (eds) Vasopressin and Oxytocin. Advances in Experimental Medicine and Biology, vol 449. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4871-3_60
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4871-3_60
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7210-3
Online ISBN: 978-1-4615-4871-3
eBook Packages: Springer Book Archive